Biemond I, Crobach L F, Jansen J B, Lamers C B
Department of Gastroenterology and Hepatology, University Hospital, Leiden, The Netherlands.
Eur J Clin Pharmacol. 1989;37(4):345-9. doi: 10.1007/BF00558498.
A study has been done in 10 male healthy volunteers of the effect of oral omeprazole 20 mg daily for 3 days on the serum concentrations of Pepsinogens A and C in relation to changes in fasting serum gastrin and basal and pentagastrin stimulated gastric acid output. The concentrations of Pepsinogens A and C showed concomitant and variable but significant increases, and the Pepsinogen A, C ratio did not change during the 3-day course of omeprazole. The increments were also significantly correlated with the increase in fasting serum gastrin and with the reduction in pentagastrin stimulated acid output. The correlations were mainly due to the marked inhibition of gastric acid secretion and the corresponding increases in serum gastrin and Pepsinogens A and C in two subjects, as in the other 8 subjects the changes were only modest. There appears to be a relationship, therefore, between the degree of inhibition of acid by omeprazole and the parallel increases in both serum pepsinogens and fasting gastrin.
一项针对10名男性健康志愿者开展的研究,观察了连续3天每日口服20毫克奥美拉唑对胃蛋白酶原A和C血清浓度的影响,以及与空腹血清胃泌素变化、基础胃酸分泌量和五肽胃泌素刺激胃酸分泌量的关系。胃蛋白酶原A和C的浓度呈现出伴随性、多变但显著的升高,且在奥美拉唑治疗的3天过程中,胃蛋白酶原A与C的比值未发生变化。这些升高还与空腹血清胃泌素的增加以及五肽胃泌素刺激胃酸分泌量的减少显著相关。这种相关性主要归因于两名受试者胃酸分泌受到显著抑制,以及血清胃泌素、胃蛋白酶原A和C相应增加,因为在其他8名受试者中,变化仅为适度。因此,奥美拉唑对胃酸的抑制程度与血清胃蛋白酶原和空腹胃泌素的平行增加之间似乎存在关联。